By Katherine Ellen Foley

The companies plan to finish submitting data to the Food and Drug Administration this week.

The companies plan to finish submitting data to the Food and Drug Administration this week.

The companies plan to finish submitting data to the Food and Drug Administration this week.

The company met its study goals, but experts are split over whether the data will be sufficient for the Food and Drug Administration.

The company met its study goals, but experts are split over whether the data will be sufficient for the Food and Drug Administration.

The company met its study goals, but experts are split over whether the data will be sufficient for the Food and Drug Administration.

The company met its study goals, but experts are split over whether the data will be sufficient for the Food and Drug Administration.

The Biden administration has been eyeing boosters to keep vulnerable populations out of hospitals.

The Biden administration has been eyeing boosters to keep vulnerable populations out of hospitals.

The company met its study goals, but experts are split over whether the data will be sufficient for the Food and Drug Administration.

The Biden administration has been eyeing boosters to keep vulnerable populations out of hospitals.

The upcoming trials will test the drug at different doses for children as young as 6 years old who test positive for Covid-19 and are not hospitalized, but are also at risk of developing severe disease.

The upcoming trials will test the drug at different doses for children as young as 6 years old who test positive for Covid-19 and are not hospitalized, but are also at risk of developing severe disease.

To users, these vapes are identical. But because of an obscure loophole, they skirt the FDA’s regulatory umbrella.

To users, these vapes are identical. But because of an obscure loophole, they skirt the FDA’s regulatory umbrella.

FDA approved the drug on an accelerated pathway, which requires a fourth clinical trial to demonstrate that the drug actually slows cognitive decline.

FDA approved the drug on an accelerated pathway, which requires a fourth clinical trial to demonstrate that the drug actually slows cognitive decline.

FDA approved the drug on an accelerated pathway, which requires a fourth clinical trial to demonstrate that the drug actually slows cognitive decline.

FDA approved the drug on an accelerated pathway, which requires a fourth clinical trial to demonstrate that the drug actually slows cognitive decline.

FDA approved the drug on an accelerated pathway, which requires a fourth clinical trial to demonstrate that the drug actually slows cognitive decline.

The companies submitted Phase III clinical trial data to FDA as a supplemental application for their vaccine, which is already approved for adults and children as young as 16.

The companies submitted Phase III clinical trial data to FDA as a supplemental application for their vaccine, which is already approved for adults and children as young as 16.

The 13-10 vote puts the simple, at-home treatment, called molnupiravir, on track for FDA approval.

The 13-10 vote puts the simple, at-home treatment, called molnupiravir, on track for FDA approval.

Robert Califf, who President Joe Biden nominated this month to lead the agency, is being looked to by forces from all sides as someone who can reboot the FDA’s Center for Tobacco Products.

Any adult may now receive a Moderna or Pfizer booster regardless of the which FDA-authorized vaccination course they received previously.

Any adult may now receive a Moderna or Pfizer booster regardless of the which FDA-authorized vaccination course they received previously.